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Introduction 
 
Leishmaniasis is used to describe the diseases as-
sociated with known species of Leishmania para-
site. The parasites are transmitted by the bite of 
sandflies (Family: Psychodidae. Subfamily: Phle-
botominae). Due to species of the Leishmania and 
the host immune response it can cause different 
clinical entities (1, 2). Leishmaniasis is endemic in 
98 countries with more than 350 million people 
at risk. CL is the most common form with 1.5 
million new cases per year (3). In the old world, 
common parasites were L. major and L. tropica 
transmitted by Phlebotomus papatasi and P. sregenti 
respectively. In The new world, CL is caused by 
L. Braziliensis, L. amazonensis and L. mexicana 
which vectors are Lutzomyia wellcomei and L. flavis-
cutellata (1). 
Up to 90% of cases of CL occur in Afghanistan, 
Algeria, Islamic Republic of Iran, Saudi Arabia 
and the Syrian Arab Republic, in Bolivia and Bra-
zil, Colombia, Nicaragua and Peru (3). Both form 
of rural and urban CL, Zoonotic CL (ZCL) and 
Anthroponotic CL (ACL) are existing in foci of 
the disease in Iran (4). About 20,000 cases of CL 
are reported every year and the actual number 
may be 4 or 5 times higher (4-6). In fact, CL is 
considered one of the most important parasitic 
diseases in Iran with a few reports of atypical 
clinical forms (7).  
Annually several cases of CL are reported in en-
demic area of Kashan (Isfahan Province, central 
Iran). 
Here a case of ocular leishmaniasis (OL) with 
eyelid involvement is reported. The disease was 
diagnosed by direct smear, culture of lesion, and 
PCR for L. major, and L. tropica by RAPD-PCR 
method which compared to reference stocks: L. 
tropica (MHOM/IR/IR/99) and L. major 
(MHOM/IR/75/ER) and the results were ob-
tained. The data related to the patient was ana-
lyzed by descriptive statistics and bands of PCR 
product was compared to the standard marker 
(XIV) strains (Fig. 1). 
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Fig. 1: RAPD-PCR technique results in isolated strain 
and standards: 1- L. tropica (MHOM/IR/IR/99), 2- L. 
major (MHOM/IR/75/ER), 3- Marker (100 bp), 4-
Unknown strain 
 
Case report 
 
A 70-year-old housewife woman with a com-
plaint of an ulcerative lesion on her upper lid of 
left eye which was non pruritic was referred to a 
health center of Kashan (Fig. 2). The lesion size 
was about 2 cm in 1 cm, was not tender, and was 
crusty and painless. Her wound was a small no-
dule initially, enlarged slowly, and after about a 
month became to current form. At the beginning, 
the antibiotic treatment was performed for 10 
days that failed to heal the lesion. Direct smears 
were taken from the edge of skin lesion of patient 
by using vaccine style and were fixed with pure 
methanol. Following the staining of samples by 
Giemsa, CL was confirmed by observation of the 
leishman bodies (amastigotes) by a light micro-
scopy (Fig. 3). After culture examination on 
NNN medium, PCR was positive for L. major.  
The patient treated with systemic meglumine an-
timonate (Glucantime) for 20 days (20 
mg/kg/day). Three months after treatment, the 
lesion healed and only a small scar was remained 
on the surface of the eyelid. 
 
 
 
Fig. 2: A 70-yr-old woman with lesion of left eyelid 
 
 
 
Fig. 3: Direct Smear was positive for Leishman bo-
dies (Giemsa stain) 
 
Discussion 
 
Cutaneous leishmaniasis is transmitted by the bite 
of infected female sand flies with Leishmania para-
sites. Because of sandflies, mouthparts are very 
short; they are unable to bite through clothing. 
Therefore, CL usually occurs in an uncovered 
part of body (1, 8). Although the face is an ex-
posed area, but it is an unusual site specially eye-
lids (6, 9). The possibility of presence of eyelash-
es and the frequent movements of the eyelids 
prevent sand fly bites (8, 10). In the season of 
sandflies activity, more blood sucking is occurred 
from sunset to sunrise (1). Although bite of eye-
lids is possible during the rest and sleep, but inci-
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dence of cases is much less than bites of the oth-
er body parts such as hands and feet. The studies 
on epidemiology of ocular leishmaniasis confirm 
the reality that this disease has low incidence (2). 
In Turkey, 33 ocular leishmaniasis in 987 (1.93%) 
and 2 out of 718 (0.3%) patients with CL respec-
tively were reported (11, 12). In Iran, Modarres-
Zadeh et al. reported four cases of OL from 1950 
to 2005 that two of them ended in blindness (2). 
L. major was the main agent of the unusual leish-
maniasis in this study and in some cases reported 
from Iran (6, 10, 13, 14). 
Although CL is a self-limiting disease, but un-
treated ocular leishmaniasis may cause ophthal-
mologic side effects and can potentially be very 
serious for eyes. Early diagnosis and vigorous 
treatment may prevent blindness (2, 15). Now 
there is no effective vaccine to prevent the dis-
ease and treatment is done with drugs (16, 17). 
The Pentavalent antimonial compounds are the 
first line drugs of treatment for all forms of 
leishmaniasis (18).  
CL is endemic in many parts of Iran and ocular 
leishmaniasis should be considered in these areas. 
In recent years some cases of ocular leishmaniasis 
has been reported in Iran (2, 9, 15).  Diagnosis 
and treatment of leishmaniasis is done free in 
Iran. North of Isfahan Province is one the en-
demic areas for CL caused by L. major (19). The 
described case is a native person who is living in 
endemic area Kashan County and had no history 
of trip to other endemic areas of Iran.  
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